Jinling Pharmaceutical Co Ltd Net Asset Momentum
Jinling Pharmaceutical Co Ltd net asset momentum. Jinling Pharmaceutical Co Ltd (000919) recorded a net asset momentum of 31.6% as of December 2024, with net assets of CN¥4.85 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does Jinling Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Jinling Pharmaceutical Co Ltd (1996–2024)
Net asset momentum of Jinling Pharmaceutical Co Ltd from 1996 to 2024. This chart tracks Jinling Pharmaceutical Co Ltd's year-over-year net asset growth across 29 annual reporting periods from 1996 to 2024. The most recent momentum reading is +31.6%, with net assets of CN¥4.85 Billion CNY as of December 2024. See Jinling Pharmaceutical Co Ltd (000919) shareholders funds for net asset value and shareholders' equity analysis.
Jinling Pharmaceutical Co Ltd Net Asset Momentum by Year (1996–2024)
Jinling Pharmaceutical Co Ltd net asset momentum by year from 1996 to 2024. The table below shows the complete annual net asset history for Jinling Pharmaceutical Co Ltd from 1996 to 2024, covering 29 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Jinling Pharmaceutical Co Ltd market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥4.85 Billion | CN¥6.09 Billion | CN¥1.24 Billion | ▲ +31.6% |
| 2023 | CN¥3.68 Billion | CN¥4.55 Billion | CN¥865.58 Million | ▲ +1.6% |
| 2022 | CN¥3.63 Billion | CN¥4.54 Billion | CN¥916.30 Million | ▲ +2.6% |
| 2021 | CN¥3.53 Billion | CN¥4.45 Billion | CN¥913.10 Million | ▲ +3.0% |
| 2020 | CN¥3.43 Billion | CN¥4.28 Billion | CN¥850.43 Million | ▲ +0.2% |
| 2019 | CN¥3.42 Billion | CN¥4.16 Billion | CN¥733.62 Million | ▲ +5.5% |
| 2018 | CN¥3.25 Billion | CN¥3.88 Billion | CN¥638.90 Million | ▲ +6.3% |
| 2017 | CN¥3.05 Billion | CN¥3.86 Billion | CN¥803.11 Million | ▲ +0.0% |
| 2016 | CN¥3.05 Billion | CN¥3.86 Billion | CN¥804.90 Million | ▲ +4.4% |
| 2015 | CN¥2.92 Billion | CN¥3.85 Billion | CN¥925.73 Million | ▲ +6.3% |
| 2014 | CN¥2.75 Billion | CN¥3.62 Billion | CN¥871.24 Million | ▲ +6.9% |
| 2013 | CN¥2.57 Billion | CN¥3.30 Billion | CN¥729.94 Million | ▲ +4.4% |
| 2012 | CN¥2.47 Billion | CN¥3.20 Billion | CN¥733.12 Million | ▲ +6.0% |
| 2011 | CN¥2.33 Billion | CN¥2.96 Billion | CN¥633.01 Million | ▲ +5.7% |
| 2010 | CN¥2.20 Billion | CN¥2.74 Billion | CN¥544.47 Million | ▲ +7.0% |
| 2009 | CN¥2.05 Billion | CN¥2.46 Billion | CN¥400.59 Million | ▲ +9.4% |
| 2008 | CN¥1.88 Billion | CN¥2.20 Billion | CN¥324.25 Million | ▼ -3.6% |
| 2007 | CN¥1.95 Billion | CN¥2.37 Billion | CN¥416.86 Million | ▲ +14.8% |
| 2006 | CN¥1.70 Billion | CN¥2.03 Billion | CN¥330.39 Million | ▲ +8.7% |
| 2005 | CN¥1.56 Billion | CN¥1.84 Billion | CN¥280.42 Million | ▲ +6.4% |
| 2004 | CN¥1.47 Billion | CN¥1.79 Billion | CN¥322.83 Million | ▲ +6.5% |
| 2003 | CN¥1.38 Billion | CN¥1.64 Billion | CN¥256.06 Million | ▲ +11.1% |
| 2002 | CN¥1.24 Billion | CN¥1.54 Billion | CN¥296.79 Million | ▲ +11.8% |
| 2001 | CN¥1.11 Billion | CN¥1.42 Billion | CN¥306.54 Million | ▲ +4.6% |
| 2000 | CN¥1.06 Billion | CN¥1.22 Billion | CN¥161.37 Million | ▲ +4.2% |
| 1999 | CN¥1.02 Billion | CN¥1.17 Billion | CN¥153.24 Million | ▲ +225.4% |
| 1998 | CN¥312.85 Million | CN¥432.49 Million | CN¥119.63 Million | ▲ +38.5% |
| 1997 | CN¥225.93 Million | CN¥306.16 Million | CN¥80.23 Million | ▲ +32.8% |
| 1996 | CN¥170.16 Million | CN¥247.41 Million | CN¥77.25 Million | — |